Gone to pot–a review of the association between cannabis and psychosis
Cannabis is the most commonly used illicit drug worldwide, with~ 5 million daily users
worldwide. Emerging evidence supports a number of associations between cannabis and …
worldwide. Emerging evidence supports a number of associations between cannabis and …
Human laboratory studies on cannabinoids and psychosis
Some of the most compelling evidence supporting an association between cannabinoid
agonists and psychosis comes from controlled laboratory studies in humans. Randomized …
agonists and psychosis comes from controlled laboratory studies in humans. Randomized …
Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia
Mismatch negativity (MMN) is among the best established biomarkers of cortical dysfunction
in schizophrenia. MMN generators are localized primarily to primary and secondary auditory …
in schizophrenia. MMN generators are localized primarily to primary and secondary auditory …
Clinical classification in mental health at the cross-roads: which direction next?
Background After 30 years of consensus-derived diagnostic categories in mental health, it is
time to head in new directions. Those categories placed great emphasis on enhanced …
time to head in new directions. Those categories placed great emphasis on enhanced …
Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders
MB Sami, S Bhattacharyya - Journal of Psychopharmacology, 2018 - journals.sagepub.com
A substantial body of credible evidence has accumulated that suggest that cannabis use is
an important potentially preventable risk factor for the development of psychotic illness and …
an important potentially preventable risk factor for the development of psychotic illness and …
[HTML][HTML] Use of cognitive event-related potentials in the management of psychiatric disorders: Towards an individual follow-up and multi-component clinical approach
S Campanella - World journal of psychiatry, 2021 - ncbi.nlm.nih.gov
Relapse prevention remains a major challenge in psychiatry, thus indicating that the
established treatment methods combining psychotherapy with neuropharmacological …
established treatment methods combining psychotherapy with neuropharmacological …
Longitudinal associations between mismatch negativity and disability in early schizophrenia-and affective-spectrum disorders
Background Impaired mismatch negativity (MMN) is a robust finding in schizophrenia and,
more recently, similar impairments have been reported in other psychotic-and affective …
more recently, similar impairments have been reported in other psychotic-and affective …
Auditory mismatch detection, distraction, and attentional reorientation (MMN-P3a-RON) in neurological and psychiatric disorders: A review
E Justo-Guillén, J Ricardo-Garcell… - International Journal of …, 2019 - Elsevier
Involuntary attention allows for the detection and processing of novel and potentially
relevant stimuli that lie outside of cognitive focus. These processes comprise change …
relevant stimuli that lie outside of cognitive focus. These processes comprise change …
Chronic effects of cannabis use on the auditory mismatch negativity
Background Cannabis use is associated with the development of psychotic symptoms and
increased risk for schizophrenia. The mismatch negativity (MMN) is a brain event-related …
increased risk for schizophrenia. The mismatch negativity (MMN) is a brain event-related …
Acute effects of Δ9-tetrahydrocannabinol and cannabidiol on auditory mismatch negativity
LM Greenwood, SJ Broyd, HH van Hell, J Todd… - …, 2022 - Springer
Rationale Mismatch negativity (MMN) is a candidate endophenotype for schizophrenia
subserved by N-methyl-D-aspartate receptor (NMDAR) function and there is increasing …
subserved by N-methyl-D-aspartate receptor (NMDAR) function and there is increasing …